Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial

MLA

Paavo V.H. Raittinen, et al. “Atorvastatin Induces Adrenal Androgen Downshift in Men with Prostate Cancer: A Post Hoc Analysis of a Pilot Adaptive Randomised Clinical Trial.” EBioMedicine, vol. 68, no. 103432-, June 2021. EBSCOhost, https://doi.org/10.1016/j.ebiom.2021.103432.

APA

Paavo V.H. Raittinen, Heimo Syvälä, Teuvo L.J. Tammela, Merja R. Häkkinen, Pauliina Ilmonen, Seppo Auriola, & Teemu J. Murtola. (2021). Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial. EBioMedicine, 68(103432-). https://doi.org/10.1016/j.ebiom.2021.103432

Chicago

Paavo V.H. Raittinen, Heimo Syvälä, Teuvo L.J. Tammela, Merja R. Häkkinen, Pauliina Ilmonen, Seppo Auriola, and Teemu J. Murtola. 2021. “Atorvastatin Induces Adrenal Androgen Downshift in Men with Prostate Cancer: A Post Hoc Analysis of a Pilot Adaptive Randomised Clinical Trial.” EBioMedicine 68 (103432-). doi:10.1016/j.ebiom.2021.103432.